F11R | F11 receptor | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAM3C | Family with sequence similarity 3, member C | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
FBLN1 | Fibulin 1 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FLNA | Filamin A, alpha | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FLNB | Filamin B, beta | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
FMNL1 | Formin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins
| | | | | Tissue enriched |
FRYL | FRY-like | Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
FUT8 | Fucosyltransferase 8 (alpha (1,6) fucosyltransferase) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GALNT7 | Polypeptide N-acetylgalactosaminyltransferase 7 | Predicted intracellular proteins
| | | | | Mixed |
GCLC | Glutamate-cysteine ligase, catalytic subunit | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GNS | Glucosamine (N-acetyl)-6-sulfatase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
GOLIM4 | Golgi integral membrane protein 4 | Predicted membrane proteins
| | | | | Expressed in all |
GOLM1 | Golgi membrane protein 1 | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GRHL1 | Grainyhead-like 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
GSN | Gelsolin | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
HLA-DRA | Major histocompatibility complex, class II, DR alpha | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HLA-E | Major histocompatibility complex, class I, E | Predicted membrane proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM3 | Intercellular adhesion molecule 3 | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGA6 | Integrin, alpha 6 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAV | Integrin, alpha V | Cancer-related genes CD markers FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAX | Integrin, alpha X (complement component 3 receptor 4 subunit) | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGB4 | Integrin, beta 4 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LAG3 | Lymphocyte-activation gene 3 | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMP1 | Lysosomal-associated membrane protein 1 | CD markers Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
LAT | Linker for activation of T cells | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LAT2 | Linker for activation of T cells family, member 2 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
LBR | Lamin B receptor | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
LMAN1 | Lectin, mannose-binding, 1 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |